Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tgif1
|
ENSMUSG00000047407.11 | Tgif1 |
Meis3
|
ENSMUSG00000041420.12 | Meis3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Meis3 | chr7_16173237_16173554 | 1695 | 0.247214 | -0.37 | 3.2e-03 | Click! |
Meis3 | chr7_16173750_16174029 | 1201 | 0.343344 | -0.31 | 1.4e-02 | Click! |
Meis3 | chr7_16175271_16176119 | 265 | 0.863591 | -0.30 | 1.9e-02 | Click! |
Meis3 | chr7_16172296_16172467 | 2709 | 0.171821 | -0.28 | 2.9e-02 | Click! |
Meis3 | chr7_16172679_16172830 | 2336 | 0.189908 | -0.27 | 3.6e-02 | Click! |
Tgif1 | chr17_70848658_70849785 | 423 | 0.710402 | -0.44 | 4.2e-04 | Click! |
Tgif1 | chr17_70850387_70852082 | 27 | 0.950916 | -0.38 | 2.5e-03 | Click! |
Tgif1 | chr17_70852401_70853022 | 835 | 0.352082 | -0.38 | 3.0e-03 | Click! |
Tgif1 | chr17_70847820_70848429 | 954 | 0.382425 | -0.34 | 7.2e-03 | Click! |
Tgif1 | chr17_70848457_70848608 | 1112 | 0.326453 | -0.34 | 7.8e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_54991806_54993467 | 15.28 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
1055 |
0.25 |
chr5_125386055_125387945 | 12.57 |
Ubc |
ubiquitin C |
2186 |
0.18 |
chr7_141506053_141507038 | 11.49 |
Gm45416 |
predicted gene 45416 |
12058 |
0.08 |
chr14_54964935_54965983 | 10.87 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
1115 |
0.21 |
chr15_41868535_41869588 | 10.76 |
Abra |
actin-binding Rho activating protein |
659 |
0.72 |
chr2_173024069_173026002 | 9.88 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr4_154024404_154026596 | 9.82 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chr3_138067510_138069146 | 9.52 |
Gm5105 |
predicted gene 5105 |
940 |
0.46 |
chr7_44482378_44484029 | 9.50 |
5430431A17Rik |
RIKEN cDNA 5430431A17 gene |
1314 |
0.19 |
chr11_115899671_115901427 | 9.31 |
Smim5 |
small integral membrane protein 5 |
347 |
0.75 |
chr17_81737002_81738450 | 9.25 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr13_109633845_109634469 | 8.78 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
1377 |
0.62 |
chr8_120292266_120293650 | 8.74 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr4_156254311_156255909 | 8.73 |
Samd11 |
sterile alpha motif domain containing 11 |
106 |
0.87 |
chr6_71261958_71262263 | 8.69 |
Smyd1 |
SET and MYND domain containing 1 |
122 |
0.93 |
chr8_122546551_122549259 | 8.62 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr2_17458500_17459039 | 8.60 |
Nebl |
nebulette |
1852 |
0.47 |
chr19_45230983_45235468 | 8.56 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr15_66560466_66561298 | 8.49 |
Tmem71 |
transmembrane protein 71 |
221 |
0.94 |
chr11_102360845_102363484 | 8.44 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr2_127369985_127371247 | 8.42 |
Adra2b |
adrenergic receptor, alpha 2b |
7330 |
0.15 |
chr10_81195163_81195734 | 8.20 |
Atcayos |
ataxia, cerebellar, Cayman type, opposite strand |
757 |
0.35 |
chr10_127749619_127751660 | 8.20 |
Gpr182 |
G protein-coupled receptor 182 |
1093 |
0.28 |
chr6_87429843_87431054 | 8.18 |
Bmp10 |
bone morphogenetic protein 10 |
1454 |
0.34 |
chr14_63268302_63270010 | 7.94 |
Gata4 |
GATA binding protein 4 |
1968 |
0.31 |
chr7_143005720_143007083 | 7.72 |
Tspan32 |
tetraspanin 32 |
473 |
0.68 |
chr6_53986001_53986442 | 7.69 |
4921529L05Rik |
RIKEN cDNA 4921529L05 gene |
7492 |
0.2 |
chr19_56388806_56389568 | 7.61 |
Nrap |
nebulin-related anchoring protein |
690 |
0.66 |
chr5_139796771_139798844 | 7.55 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
293 |
0.85 |
chrX_159942973_159943935 | 7.55 |
Sh3kbp1 |
SH3-domain kinase binding protein 1 |
436 |
0.87 |
chr15_27855911_27856907 | 7.35 |
Gm9891 |
predicted gene 9891 |
102 |
0.96 |
chr14_54990541_54991364 | 7.26 |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
2739 |
0.09 |
chr3_127123282_127124895 | 7.24 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr10_117046957_117047576 | 7.23 |
Lrrc10 |
leucine rich repeat containing 10 |
1925 |
0.23 |
chr4_106581338_106582731 | 7.05 |
Gm12744 |
predicted gene 12744 |
7074 |
0.12 |
chr8_34120422_34121003 | 7.04 |
Gm39158 |
predicted gene, 39158 |
504 |
0.65 |
chr3_123033789_123034940 | 7.00 |
Myoz2 |
myozenin 2 |
480 |
0.73 |
chr8_45660711_45661611 | 6.88 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
832 |
0.66 |
chr7_48847211_48847926 | 6.86 |
Csrp3 |
cysteine and glycine-rich protein 3 |
465 |
0.76 |
chr3_148922298_148922891 | 6.83 |
Adgrl2 |
adhesion G protein-coupled receptor L2 |
32041 |
0.19 |
chr8_10363758_10364251 | 6.82 |
Myo16 |
myosin XVI |
91432 |
0.09 |
chr14_31209518_31210345 | 6.75 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
1599 |
0.22 |
chr1_135799428_135800706 | 6.75 |
Tnni1 |
troponin I, skeletal, slow 1 |
234 |
0.9 |
chr7_44350602_44354420 | 6.73 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1749 |
0.15 |
chr15_40665481_40666389 | 6.71 |
Zfpm2 |
zinc finger protein, multitype 2 |
945 |
0.71 |
chr13_109632540_109633637 | 6.60 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
308 |
0.95 |
chr7_16793181_16794023 | 6.52 |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
425 |
0.73 |
chr11_75165245_75169157 | 6.47 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr2_76982792_76983214 | 6.41 |
Ttn |
titin |
456 |
0.86 |
chr19_36117188_36117519 | 6.35 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
2557 |
0.28 |
chr9_107975554_107976970 | 6.32 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr16_35159310_35160996 | 6.32 |
Adcy5 |
adenylate cyclase 5 |
5276 |
0.25 |
chr10_111519714_111520522 | 6.30 |
Phlda1 |
pleckstrin homology like domain, family A, member 1 |
12422 |
0.13 |
chr5_99339481_99340596 | 6.28 |
Gm35394 |
predicted gene, 35394 |
65943 |
0.12 |
chr2_114051146_114052179 | 6.24 |
Actc1 |
actin, alpha, cardiac muscle 1 |
1225 |
0.4 |
chr15_92634199_92634441 | 6.21 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
37194 |
0.2 |
chr11_77802176_77803137 | 6.17 |
Myo18a |
myosin XVIIIA |
1281 |
0.39 |
chr2_181155937_181157234 | 6.13 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr10_80314572_80317647 | 6.13 |
2310011J03Rik |
RIKEN cDNA 2310011J03 gene |
4428 |
0.07 |
chr4_5724213_5725550 | 6.10 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr5_107724563_107727169 | 6.10 |
Gfi1 |
growth factor independent 1 transcription repressor |
61 |
0.88 |
chr5_149713426_149714289 | 6.08 |
B3glct |
beta-3-glucosyltransferase |
25675 |
0.15 |
chr2_148441004_148443557 | 6.05 |
Cd93 |
CD93 antigen |
1283 |
0.41 |
chr8_23035959_23037041 | 6.03 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr11_31872311_31873528 | 5.97 |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
356 |
0.89 |
chr12_86360988_86362126 | 5.95 |
Esrrb |
estrogen related receptor, beta |
440 |
0.84 |
chr2_180389757_180390438 | 5.94 |
Mir1a-1 |
microRNA 1a-1 |
1049 |
0.41 |
chr1_118481967_118482873 | 5.92 |
Clasp1 |
CLIP associating protein 1 |
381 |
0.8 |
chr11_103102696_103105788 | 5.90 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr2_114055154_114055663 | 5.89 |
C130080G10Rik |
RIKEN cDNA C130080G10 gene |
161 |
0.93 |
chr1_188006897_188007904 | 5.89 |
9330162B11Rik |
RIKEN cDNA 9330162B11 gene |
1590 |
0.45 |
chr1_133245733_133247220 | 5.83 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
370 |
0.84 |
chr11_22170917_22171472 | 5.83 |
Ehbp1 |
EH domain binding protein 1 |
216 |
0.96 |
chr12_105034788_105035573 | 5.78 |
Glrx5 |
glutaredoxin 5 |
36 |
0.95 |
chr6_55132322_55132945 | 5.77 |
Crhr2 |
corticotropin releasing hormone receptor 2 |
208 |
0.93 |
chr1_166126774_166128045 | 5.74 |
Dusp27 |
dual specificity phosphatase 27 (putative) |
487 |
0.76 |
chr2_30995683_30996883 | 5.73 |
Usp20 |
ubiquitin specific peptidase 20 |
235 |
0.9 |
chr10_80856664_80858456 | 5.71 |
Sppl2b |
signal peptide peptidase like 2B |
439 |
0.61 |
chr16_19981596_19982182 | 5.66 |
Klhl6 |
kelch-like 6 |
1041 |
0.58 |
chr5_32990256_32991187 | 5.66 |
Gm43693 |
predicted gene 43693 |
6151 |
0.16 |
chr9_77637137_77637792 | 5.63 |
Klhl31 |
kelch-like 31 |
964 |
0.54 |
chr2_91120847_91121416 | 5.62 |
Mybpc3 |
myosin binding protein C, cardiac |
2987 |
0.16 |
chr10_63457257_63458786 | 5.62 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
511 |
0.78 |
chr1_181334992_181336043 | 5.60 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17111 |
0.15 |
chr14_31208319_31209141 | 5.60 |
Tnnc1 |
troponin C, cardiac/slow skeletal |
398 |
0.71 |
chr2_14606771_14607222 | 5.60 |
Cacnb2 |
calcium channel, voltage-dependent, beta 2 subunit |
1874 |
0.21 |
chr18_35720849_35722653 | 5.59 |
Ecscr |
endothelial cell surface expressed chemotaxis and apoptosis regulator |
260 |
0.83 |
chr19_53194082_53195694 | 5.57 |
Add3 |
adducin 3 (gamma) |
65 |
0.97 |
chr11_120647315_120648501 | 5.57 |
Myadml2 |
myeloid-associated differentiation marker-like 2 |
202 |
0.49 |
chr11_84822134_84823653 | 5.57 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
3378 |
0.15 |
chr17_26849670_26851386 | 5.56 |
Nkx2-5 |
NK2 homeobox 5 |
5519 |
0.11 |
chr10_59403301_59404650 | 5.56 |
Pla2g12b |
phospholipase A2, group XIIB |
315 |
0.88 |
chr8_14683396_14684419 | 5.55 |
Dlgap2 |
DLG associated protein 2 |
58846 |
0.13 |
chr5_113973724_113975031 | 5.54 |
Ssh1 |
slingshot protein phosphatase 1 |
7621 |
0.13 |
chr11_104578496_104579513 | 5.52 |
Myl4 |
myosin, light polypeptide 4 |
1321 |
0.29 |
chr15_98605967_98606147 | 5.48 |
Adcy6 |
adenylate cyclase 6 |
1231 |
0.27 |
chr5_77113895_77114483 | 5.48 |
Hopx |
HOP homeobox |
932 |
0.47 |
chr8_85380167_85381092 | 5.46 |
Mylk3 |
myosin light chain kinase 3 |
349 |
0.83 |
chr8_85363277_85363745 | 5.45 |
Mylk3 |
myosin light chain kinase 3 |
1813 |
0.26 |
chr3_119498694_119499278 | 5.44 |
Gm23432 |
predicted gene, 23432 |
139888 |
0.05 |
chr13_113661831_113661982 | 5.44 |
Hspb3 |
heat shock protein 3 |
1770 |
0.32 |
chr12_44044424_44045055 | 5.43 |
Gm47056 |
predicted gene, 47056 |
77017 |
0.09 |
chr12_117657998_117660727 | 5.41 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr8_121897389_121899362 | 5.41 |
Slc7a5 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 |
1873 |
0.2 |
chr4_141421681_141422558 | 5.40 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
1340 |
0.25 |
chr15_89425017_89425997 | 5.38 |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
288 |
0.74 |
chr2_32078207_32079756 | 5.38 |
Fam78a |
family with sequence similarity 78, member A |
371 |
0.77 |
chr5_23921352_23921520 | 5.38 |
Fam126a |
family with sequence similarity 126, member A |
1468 |
0.33 |
chr6_127581934_127583022 | 5.35 |
Cracr2a |
calcium release activated channel regulator 2A |
4503 |
0.24 |
chr8_120307042_120307692 | 5.35 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
78911 |
0.08 |
chr18_60963604_60964955 | 5.34 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
679 |
0.59 |
chr2_24385363_24386049 | 5.34 |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
353 |
0.84 |
chr6_72100819_72101598 | 5.34 |
Gm29438 |
predicted gene 29438 |
2993 |
0.15 |
chr11_25156991_25157715 | 5.32 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
75273 |
0.11 |
chr15_76197527_76199931 | 5.32 |
Plec |
plectin |
520 |
0.59 |
chr1_58970537_58971332 | 5.31 |
Trak2 |
trafficking protein, kinesin binding 2 |
2495 |
0.2 |
chr2_27246009_27247328 | 5.31 |
Sardh |
sarcosine dehydrogenase |
180 |
0.94 |
chr17_10312737_10313423 | 5.31 |
Qk |
quaking |
6281 |
0.25 |
chr10_81497570_81499812 | 5.31 |
S1pr4 |
sphingosine-1-phosphate receptor 4 |
1441 |
0.16 |
chr19_45446379_45446948 | 5.30 |
Btrc |
beta-transducin repeat containing protein |
1155 |
0.47 |
chr9_50752994_50754649 | 5.28 |
Cryab |
crystallin, alpha B |
574 |
0.54 |
chr9_24772390_24773199 | 5.27 |
Tbx20 |
T-box 20 |
1490 |
0.39 |
chr4_117312229_117313344 | 5.26 |
Rnf220 |
ring finger protein 220 |
12758 |
0.13 |
chr11_59138017_59138780 | 5.24 |
Obscn |
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF |
772 |
0.52 |
chr18_62176067_62177775 | 5.24 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr8_60952376_60953209 | 5.23 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
1956 |
0.29 |
chr18_11056331_11056626 | 5.21 |
Gata6 |
GATA binding protein 6 |
1440 |
0.45 |
chr14_34587287_34588669 | 5.20 |
Ldb3 |
LIM domain binding 3 |
503 |
0.69 |
chr9_101196762_101197254 | 5.19 |
Ppp2r3a |
protein phosphatase 2, regulatory subunit B'', alpha |
1843 |
0.24 |
chr11_81587895_81588519 | 5.19 |
Gm11418 |
predicted gene 11418 |
846 |
0.69 |
chr2_91120400_91120551 | 5.19 |
Mybpc3 |
myosin binding protein C, cardiac |
2331 |
0.18 |
chr14_54962885_54964094 | 5.15 |
Myh6 |
myosin, heavy polypeptide 6, cardiac muscle, alpha |
3085 |
0.08 |
chr15_98775840_98778905 | 5.15 |
Wnt10b |
wingless-type MMTV integration site family, member 10B |
111 |
0.92 |
chr18_65393472_65393826 | 5.14 |
Alpk2 |
alpha-kinase 2 |
245 |
0.87 |
chr17_72921491_72924008 | 5.14 |
Lbh |
limb-bud and heart |
1561 |
0.47 |
chr1_51288641_51290950 | 5.13 |
Cavin2 |
caveolae associated 2 |
669 |
0.72 |
chr10_91270186_91271346 | 5.12 |
Gm18705 |
predicted gene, 18705 |
11422 |
0.18 |
chr8_120504115_120505872 | 5.11 |
Gm26971 |
predicted gene, 26971 |
15622 |
0.12 |
chr16_96205810_96206739 | 5.11 |
Sh3bgr |
SH3-binding domain glutamic acid-rich protein |
369 |
0.83 |
chr19_37172561_37172787 | 5.08 |
A330032B11Rik |
RIKEN cDNA A330032B11 gene |
1169 |
0.32 |
chr8_36731766_36732359 | 5.08 |
Dlc1 |
deleted in liver cancer 1 |
992 |
0.69 |
chr1_75445319_75447338 | 5.07 |
Gmppa |
GDP-mannose pyrophosphorylase A |
4104 |
0.1 |
chr1_131275635_131276472 | 5.05 |
Ikbke |
inhibitor of kappaB kinase epsilon |
660 |
0.58 |
chr13_59818297_59819205 | 5.04 |
Tut7 |
terminal uridylyl transferase 7 |
3837 |
0.13 |
chr5_125056018_125058841 | 5.01 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr12_99457193_99458078 | 5.00 |
Foxn3 |
forkhead box N3 |
7538 |
0.2 |
chr9_105520039_105521535 | 5.00 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr16_90043846_90044623 | 5.00 |
Gm2805 |
predicted gene 2805 |
45749 |
0.15 |
chr9_50451843_50452572 | 4.99 |
Plet1 |
placenta expressed transcript 1 |
42318 |
0.11 |
chr5_122101598_122101934 | 4.97 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
31 |
0.97 |
chr4_40850475_40851213 | 4.97 |
Gm25931 |
predicted gene, 25931 |
442 |
0.43 |
chr18_4995747_4996610 | 4.91 |
Svil |
supervillin |
1242 |
0.62 |
chr5_57721137_57722906 | 4.91 |
Pcdh7 |
protocadherin 7 |
108 |
0.94 |
chr9_72448745_72450029 | 4.90 |
Gm27231 |
predicted gene 27231 |
7608 |
0.08 |
chr15_76666348_76670076 | 4.89 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr18_73691457_73692186 | 4.88 |
Smad4 |
SMAD family member 4 |
11959 |
0.15 |
chr2_160472979_160473873 | 4.88 |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
106361 |
0.06 |
chr4_148960341_148961414 | 4.87 |
Gm17029 |
predicted gene 17029 |
517 |
0.74 |
chr10_69785224_69786670 | 4.87 |
Ank3 |
ankyrin 3, epithelial |
422 |
0.91 |
chr3_142429664_142430381 | 4.83 |
Pdlim5 |
PDZ and LIM domain 5 |
34326 |
0.16 |
chr2_155611238_155612364 | 4.83 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
589 |
0.53 |
chr2_121035039_121035972 | 4.82 |
Epb42 |
erythrocyte membrane protein band 4.2 |
1176 |
0.33 |
chr8_84934799_84937325 | 4.82 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
1282 |
0.19 |
chr1_23321078_23322043 | 4.82 |
Gm20954 |
predicted gene, 20954 |
25039 |
0.11 |
chr9_107401822_107402928 | 4.80 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
2306 |
0.19 |
chr1_131232374_131233673 | 4.78 |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
552 |
0.67 |
chr12_80778068_80778854 | 4.78 |
Gm47941 |
predicted gene, 47941 |
11882 |
0.12 |
chr19_10015065_10016667 | 4.78 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr15_73750483_73751713 | 4.78 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
2724 |
0.24 |
chr4_135314305_135314767 | 4.75 |
Gm12982 |
predicted gene 12982 |
6566 |
0.12 |
chr19_36734732_36735279 | 4.75 |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
1648 |
0.41 |
chr14_63235525_63236294 | 4.72 |
Gata4 |
GATA binding protein 4 |
9339 |
0.17 |
chr7_133700764_133701966 | 4.71 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr3_138069501_138070764 | 4.70 |
1110002E22Rik |
RIKEN cDNA 1110002E22 gene |
1465 |
0.3 |
chr16_38370407_38370971 | 4.70 |
Popdc2 |
popeye domain containing 2 |
1263 |
0.34 |
chr8_84836764_84838739 | 4.69 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
296 |
0.75 |
chr1_37478065_37479166 | 4.69 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9990 |
0.14 |
chr9_108449561_108451508 | 4.69 |
Klhdc8b |
kelch domain containing 8B |
165 |
0.86 |
chr13_12103103_12103740 | 4.69 |
Ryr2 |
ryanodine receptor 2, cardiac |
3038 |
0.25 |
chr2_168589071_168590755 | 4.68 |
Nfatc2 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
278 |
0.93 |
chr18_37767253_37768546 | 4.67 |
Gm26672 |
predicted gene, 26672 |
343 |
0.61 |
chr5_121833321_121834947 | 4.67 |
1700008B11Rik |
RIKEN cDNA 1700008B11 gene |
1061 |
0.33 |
chr4_130173825_130175545 | 4.66 |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
6 |
0.97 |
chr19_24046811_24047201 | 4.65 |
Fam189a2 |
family with sequence similarity 189, member A2 |
15987 |
0.16 |
chr2_91119045_91119896 | 4.63 |
Mybpc3 |
myosin binding protein C, cardiac |
1326 |
0.3 |
chr8_84703616_84705950 | 4.60 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr18_84858127_84859558 | 4.59 |
Gm16146 |
predicted gene 16146 |
705 |
0.62 |
chr17_29493756_29495031 | 4.59 |
Pim1 |
proviral integration site 1 |
986 |
0.37 |
chr18_38917847_38919046 | 4.59 |
Fgf1 |
fibroblast growth factor 1 |
325 |
0.9 |
chr4_87805839_87806716 | 4.58 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
17 |
0.99 |
chr3_138066336_138066610 | 4.56 |
Gm5105 |
predicted gene 5105 |
915 |
0.41 |
chr8_104535337_104535640 | 4.56 |
Car7 |
carbonic anhydrase 7 |
788 |
0.34 |
chr10_33084458_33084609 | 4.55 |
Trdn |
triadin |
972 |
0.66 |
chr8_36608403_36609754 | 4.53 |
Dlc1 |
deleted in liver cancer 1 |
4796 |
0.31 |
chr12_52854803_52855496 | 4.53 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
59313 |
0.14 |
chr16_87705786_87706863 | 4.53 |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
7320 |
0.23 |
chr12_31711352_31711698 | 4.53 |
Gpr22 |
G protein-coupled receptor 22 |
2401 |
0.25 |
chr19_6856906_6858230 | 4.53 |
Ccdc88b |
coiled-coil domain containing 88B |
643 |
0.54 |
chr3_84477728_84478854 | 4.52 |
Fhdc1 |
FH2 domain containing 1 |
691 |
0.74 |
chr6_119195676_119196202 | 4.52 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
292 |
0.91 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
8.6 | 42.8 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
8.4 | 41.9 | GO:0003175 | tricuspid valve development(GO:0003175) |
7.8 | 7.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.9 | 13.9 | GO:0035995 | detection of muscle stretch(GO:0035995) |
5.5 | 10.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
5.4 | 16.2 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
5.3 | 15.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
4.5 | 17.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
4.2 | 4.2 | GO:0030239 | myofibril assembly(GO:0030239) |
4.2 | 4.2 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
4.2 | 16.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
4.0 | 11.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
3.9 | 15.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
3.7 | 37.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
3.6 | 7.2 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
3.6 | 10.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
3.4 | 3.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.4 | 10.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
3.3 | 6.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
3.2 | 9.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.2 | 18.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
3.0 | 9.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.9 | 11.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.9 | 8.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.9 | 8.6 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
2.7 | 10.9 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
2.7 | 10.7 | GO:0035482 | gastric motility(GO:0035482) |
2.6 | 2.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
2.5 | 7.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
2.5 | 7.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
2.5 | 9.9 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
2.4 | 7.3 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
2.4 | 7.2 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
2.4 | 7.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
2.3 | 16.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
2.3 | 4.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.3 | 4.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
2.3 | 6.9 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
2.2 | 6.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.2 | 10.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
2.2 | 4.3 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.2 | 6.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.1 | 4.2 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
2.1 | 4.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.1 | 8.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.1 | 6.2 | GO:0036166 | phenotypic switching(GO:0036166) |
2.1 | 6.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.0 | 6.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.0 | 2.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.0 | 4.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.0 | 6.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.0 | 8.0 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
2.0 | 13.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.9 | 40.5 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.9 | 1.9 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.9 | 5.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.9 | 5.7 | GO:0070836 | caveola assembly(GO:0070836) |
1.9 | 3.8 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
1.9 | 3.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.8 | 5.5 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.8 | 5.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.8 | 5.5 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.8 | 14.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.8 | 7.2 | GO:0050904 | diapedesis(GO:0050904) |
1.8 | 5.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.7 | 3.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
1.7 | 6.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.7 | 1.7 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.7 | 5.1 | GO:0021564 | vagus nerve development(GO:0021564) |
1.7 | 5.1 | GO:0008228 | opsonization(GO:0008228) |
1.7 | 5.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.7 | 8.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.7 | 5.0 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.7 | 8.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.7 | 9.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.6 | 8.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
1.6 | 4.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.6 | 4.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.6 | 4.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.6 | 4.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.5 | 1.5 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.5 | 4.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.5 | 1.5 | GO:0070295 | renal water absorption(GO:0070295) |
1.5 | 4.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.5 | 6.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.5 | 4.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.5 | 4.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.5 | 2.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.4 | 7.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.4 | 1.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.4 | 4.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
1.4 | 2.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.4 | 1.4 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
1.4 | 6.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.4 | 6.9 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.4 | 2.8 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.4 | 4.1 | GO:0007525 | somatic muscle development(GO:0007525) |
1.4 | 5.5 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.4 | 2.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.4 | 4.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.4 | 4.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 2.7 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
1.3 | 4.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.3 | 5.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.3 | 6.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.3 | 1.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.3 | 1.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.3 | 10.6 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
1.3 | 5.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.3 | 2.6 | GO:0001997 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
1.3 | 2.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.3 | 10.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.3 | 2.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.3 | 7.8 | GO:0015671 | oxygen transport(GO:0015671) |
1.3 | 3.9 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.3 | 3.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.3 | 3.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
1.3 | 10.2 | GO:0097286 | iron ion import(GO:0097286) |
1.3 | 7.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.3 | 3.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.3 | 3.8 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
1.3 | 6.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.3 | 1.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.3 | 2.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.3 | 3.8 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
1.3 | 2.5 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
1.2 | 2.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
1.2 | 3.7 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.2 | 4.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.2 | 3.7 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.2 | 1.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.2 | 3.7 | GO:0018343 | protein farnesylation(GO:0018343) |
1.2 | 1.2 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
1.2 | 2.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.2 | 2.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.2 | 3.6 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.2 | 9.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.2 | 3.6 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
1.2 | 4.8 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.2 | 1.2 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
1.2 | 7.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.2 | 2.3 | GO:0003166 | bundle of His development(GO:0003166) |
1.2 | 10.5 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.2 | 4.6 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.2 | 4.6 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
1.2 | 10.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.2 | 2.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.2 | 3.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.1 | 4.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
1.1 | 3.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.1 | 3.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.1 | 5.5 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.1 | 3.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.1 | 8.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
1.1 | 2.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.1 | 1.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
1.1 | 2.2 | GO:1903416 | response to glycoside(GO:1903416) |
1.1 | 1.1 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.1 | 5.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
1.1 | 9.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.1 | 5.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.1 | 1.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
1.1 | 4.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.1 | 2.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.1 | 9.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.1 | 11.7 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.1 | 2.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.1 | 3.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
1.1 | 3.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.1 | 2.1 | GO:0002432 | granuloma formation(GO:0002432) |
1.1 | 6.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.0 | 1.0 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
1.0 | 1.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.0 | 3.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.0 | 2.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.0 | 6.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
1.0 | 2.1 | GO:0036394 | amylase secretion(GO:0036394) |
1.0 | 7.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 8.3 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.0 | 5.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.0 | 3.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.0 | 1.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
1.0 | 15.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 7.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.0 | 3.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.0 | 2.0 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.0 | 3.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.0 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.0 | 4.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.0 | 3.0 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.0 | 5.9 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.0 | 2.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
1.0 | 3.0 | GO:0061010 | gall bladder development(GO:0061010) |
1.0 | 3.9 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
1.0 | 3.9 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
1.0 | 4.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
1.0 | 4.8 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
1.0 | 3.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.0 | 1.9 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
1.0 | 1.0 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
1.0 | 1.9 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.0 | 4.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.0 | 4.8 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.9 | 1.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.9 | 4.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 2.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.9 | 5.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.9 | 5.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.9 | 3.7 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 1.8 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.9 | 6.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.9 | 3.6 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.9 | 2.7 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.9 | 0.9 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.9 | 1.8 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.9 | 2.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.9 | 3.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.9 | 0.9 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.9 | 3.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.9 | 1.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.9 | 1.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.9 | 3.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.9 | 6.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.9 | 2.6 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.9 | 1.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.9 | 5.2 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.9 | 2.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.9 | 4.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.9 | 3.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.9 | 9.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.9 | 3.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.8 | 6.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.8 | 3.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.8 | 3.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.8 | 2.5 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.8 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.8 | 4.2 | GO:0036233 | glycine import(GO:0036233) |
0.8 | 1.7 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.8 | 2.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.8 | 1.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.8 | 3.3 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.8 | 1.6 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.8 | 1.6 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 2.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.8 | 1.6 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.8 | 2.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.8 | 4.9 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.8 | 2.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.8 | 4.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.8 | 0.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.8 | 3.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.8 | 3.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.8 | 2.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.8 | 5.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.8 | 0.8 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.8 | 5.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.8 | 2.4 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.8 | 3.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.8 | 3.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.8 | 1.6 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.8 | 1.5 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.8 | 5.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 5.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.8 | 1.5 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.8 | 3.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.8 | 0.8 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.8 | 1.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.8 | 1.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 2.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.8 | 0.8 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.8 | 3.0 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.8 | 3.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.8 | 3.0 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.8 | 1.5 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.8 | 1.5 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.8 | 0.8 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.7 | 3.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.7 | 1.5 | GO:0042420 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.7 | 4.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.7 | 0.7 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.7 | 3.0 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.7 | 2.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 2.2 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.7 | 2.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 2.2 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.7 | 5.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.7 | 4.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.7 | 2.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.7 | 5.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.7 | 3.6 | GO:0015816 | glycine transport(GO:0015816) |
0.7 | 2.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.7 | 2.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.7 | 4.3 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.7 | 3.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.7 | 5.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.7 | 3.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 1.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.7 | 12.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.7 | 6.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.7 | 2.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 2.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.7 | 2.8 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.7 | 0.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.7 | 2.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 3.5 | GO:2000318 | regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) |
0.7 | 1.4 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.7 | 1.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.7 | 11.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.7 | 5.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 6.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.7 | 2.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 2.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.7 | 6.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 3.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.7 | 2.7 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.7 | 1.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.7 | 12.9 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.7 | 2.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.7 | 2.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.7 | 2.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.7 | 1.3 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.7 | 3.3 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.7 | 2.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 1.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.6 | 2.6 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.6 | 2.6 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.6 | 2.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.6 | 1.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 1.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 2.5 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.6 | 3.8 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.6 | 0.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.6 | 0.6 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 1.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.6 | 5.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.6 | 1.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.6 | 1.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.6 | 4.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.9 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.6 | 1.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.6 | 3.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.6 | 1.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.6 | 0.6 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.6 | 13.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.6 | 4.9 | GO:0007343 | egg activation(GO:0007343) |
0.6 | 3.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 3.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.6 | 2.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.6 | 1.8 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 6.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.6 | 1.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.6 | 2.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.6 | 5.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 1.2 | GO:0009597 | detection of virus(GO:0009597) |
0.6 | 5.9 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.6 | 1.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.6 | 3.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.6 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.6 | 1.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.6 | 2.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.6 | 5.8 | GO:0006828 | manganese ion transport(GO:0006828) |
0.6 | 2.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.6 | 8.1 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.6 | 1.2 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.6 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.6 | 1.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 8.6 | GO:0045214 | sarcomere organization(GO:0045214) |
0.6 | 4.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 4.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.6 | 1.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.6 | 3.4 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.6 | 3.4 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.6 | 4.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.6 | 1.1 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.6 | 3.4 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.6 | 1.7 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.6 | 2.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.6 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 2.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 1.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 2.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.6 | 6.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.6 | 7.2 | GO:0033198 | response to ATP(GO:0033198) |
0.6 | 5.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 1.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.5 | 4.4 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.5 | 0.5 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.5 | 1.1 | GO:0015677 | copper ion import(GO:0015677) |
0.5 | 7.6 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.5 | 6.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.5 | 4.9 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.5 | 2.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 4.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.5 | 2.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 0.5 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.5 | 3.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.5 | 0.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.5 | 3.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 2.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.5 | 1.6 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.5 | 1.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.5 | 16.3 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 0.5 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 10.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 0.5 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.5 | 1.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 1.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.5 | 1.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.5 | 9.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 1.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.5 | 4.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.5 | 2.0 | GO:0046959 | habituation(GO:0046959) |
0.5 | 2.0 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 9.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 4.6 | GO:0005980 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.5 | 1.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.5 | 1.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 0.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.5 | 2.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 1.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 1.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 16.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.5 | 3.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.5 | 1.0 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.5 | 3.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 1.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 4.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.5 | 1.5 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.5 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.5 | 2.5 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
0.5 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.5 | 0.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 5.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 0.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.5 | 1.0 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.5 | 0.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 1.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 0.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 | 1.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.5 | 2.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.5 | 1.4 | GO:0060618 | nipple development(GO:0060618) |
0.5 | 6.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 2.4 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.5 | 1.9 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.5 | 0.9 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 1.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 3.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 1.9 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.5 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.5 | 2.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.5 | 2.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.5 | 0.9 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.5 | 3.7 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.5 | 0.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 0.9 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.5 | 3.7 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.5 | 1.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.5 | 1.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 1.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 4.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.5 | 1.4 | GO:0046618 | drug export(GO:0046618) |
0.5 | 1.4 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.5 | 2.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.4 | 0.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.4 | 3.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 1.8 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.4 | 1.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.4 | 1.8 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.4 | 2.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.4 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.4 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 2.2 | GO:0030730 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
0.4 | 4.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.4 | 0.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 | 0.4 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.4 | 1.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.4 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.4 | 2.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 4.3 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 0.9 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.4 | 0.4 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.4 | 1.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 0.4 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.4 | 0.4 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 1.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.4 | 2.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.4 | 0.4 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.4 | 1.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.4 | 1.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 1.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 2.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 0.8 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 1.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 3.7 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.4 | 0.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.4 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.4 | 2.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 8.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.4 | 0.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.4 | 1.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.4 | 3.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.4 | 0.8 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.4 | 0.4 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.4 | 0.4 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.4 | 0.8 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 1.2 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.4 | 2.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 2.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.4 | 2.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 1.2 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.4 | 0.4 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.4 | 2.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 1.9 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) |
0.4 | 1.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 1.2 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.4 | 0.8 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.4 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 2.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 0.8 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.4 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.4 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.4 | 1.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 1.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 3.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.4 | 6.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.4 | 3.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 1.1 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.4 | 0.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 1.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.4 | 4.7 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.4 | 1.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.4 | 0.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.4 | 0.4 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.4 | 0.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 3.9 | GO:0030431 | sleep(GO:0030431) |
0.4 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.4 | 1.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.4 | 1.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.4 | 3.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 0.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.4 | 2.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 0.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.7 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 0.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.3 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 7.9 | GO:0061515 | myeloid cell development(GO:0061515) |
0.3 | 4.1 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.3 | 0.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 0.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.7 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.3 | 1.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 2.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 1.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 1.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 1.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.3 | 2.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 0.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 0.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.3 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.3 | 1.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 0.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.3 | 1.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 1.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.3 | 1.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.3 | 9.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.3 | 1.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 2.2 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.3 | 0.3 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.3 | 2.9 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.3 | 1.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 7.0 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 1.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 0.6 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.3 | 1.3 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.3 | 1.9 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.3 | 0.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.3 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.3 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 2.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 2.2 | GO:0060746 | parental behavior(GO:0060746) |
0.3 | 1.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.3 | 0.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 0.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.3 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 0.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.9 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.3 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.3 | 3.4 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 0.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 3.7 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.3 | 0.9 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 4.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.3 | 0.3 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.3 | 1.8 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.3 | 1.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 2.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 3.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.3 | 0.3 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.3 | 5.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.3 | 1.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 1.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.3 | 2.6 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.3 | 6.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 0.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.3 | GO:0006971 | hypotonic response(GO:0006971) |
0.3 | 3.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 2.0 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.3 | 2.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.3 | 0.3 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.3 | 0.6 | GO:0060214 | endocardium formation(GO:0060214) |
0.3 | 1.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 3.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.3 | 0.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.3 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 3.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 1.1 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.3 | 3.1 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 1.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.3 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 2.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.3 | 0.3 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.3 | 1.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.3 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 1.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.3 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.3 | 1.6 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.3 | 2.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.3 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 2.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.3 | 0.3 | GO:0036296 | response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) |
0.3 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 1.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 5.2 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 2.1 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 1.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 0.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.3 | 0.3 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.3 | 1.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.3 | 1.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 0.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 0.5 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.3 | 3.8 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 2.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.5 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 0.3 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.2 | 0.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.2 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.5 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.2 | 2.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.5 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.2 | 3.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 1.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 1.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 1.5 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 0.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 1.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 1.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 1.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.7 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.2 | 0.2 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.2 | 1.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.2 | 2.4 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 0.5 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.2 | 0.2 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 2.8 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.9 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 0.9 | GO:0072526 | NADP catabolic process(GO:0006742) pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 1.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.5 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.2 | 2.6 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.2 | 4.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.7 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.2 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.5 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.2 | 0.7 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 1.4 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 2.7 | GO:0019935 | cyclic-nucleotide-mediated signaling(GO:0019935) |
0.2 | 0.7 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.9 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.2 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 0.4 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 1.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 0.7 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 0.7 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 0.7 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 0.7 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 1.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 1.3 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.2 | 0.2 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.2 | 1.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 0.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 1.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 1.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 1.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 1.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 1.9 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.2 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
0.2 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 5.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.4 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 0.2 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 2.7 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.2 | 2.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.2 | GO:2000515 | negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
0.2 | 8.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 0.2 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.2 | 0.2 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 0.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.2 | 1.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 1.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 1.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 1.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.4 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.2 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.8 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.2 | 1.9 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 1.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.9 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.2 | 1.1 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.2 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.6 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.2 | 2.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 1.8 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.2 | 0.9 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.2 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 0.5 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.2 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.2 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.3 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 3.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 0.7 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.2 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.7 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.2 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.2 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 0.2 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.2 | 0.8 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.2 | 2.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.2 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 2.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.5 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.2 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.2 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.2 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.9 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.3 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.2 | GO:2000589 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) regulation of metanephric mesenchymal cell migration(GO:2000589) |
0.2 | 0.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.8 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.2 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.5 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.8 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 1.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 1.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.6 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:2000192 | negative regulation of icosanoid secretion(GO:0032304) negative regulation of fatty acid transport(GO:2000192) |
0.1 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.3 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.1 | 0.4 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 1.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 3.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.1 | GO:0006901 | vesicle coating(GO:0006901) |
0.1 | 0.6 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.8 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.1 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 1.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.4 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.1 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.5 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.3 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 1.5 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.1 | 0.1 | GO:0009750 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.1 | 0.3 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.1 | 0.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.3 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.1 | 0.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.1 | 0.3 | GO:0030913 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) protein localization to axon(GO:0099612) |
0.1 | 0.1 | GO:0009164 | nucleoside catabolic process(GO:0009164) |
0.1 | 1.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 3.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.5 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.1 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.1 | 0.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.1 | 0.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.5 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
0.1 | 0.1 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.1 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 5.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) |
0.1 | 0.1 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 2.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.2 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.2 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.1 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.2 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.1 | 0.1 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.2 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 1.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.3 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.5 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 2.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.9 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.1 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.5 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.2 | GO:0010878 | cholesterol storage(GO:0010878) |
0.1 | 0.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 1.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 7.8 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 1.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) |
0.1 | 0.3 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
0.1 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.5 | GO:0032095 | regulation of response to food(GO:0032095) |
0.1 | 1.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.1 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.1 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.2 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.1 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0051196 | regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) |
0.1 | 0.9 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.2 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.2 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.9 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 1.9 | GO:1900373 | positive regulation of nucleotide biosynthetic process(GO:0030810) positive regulation of purine nucleotide biosynthetic process(GO:1900373) |
0.1 | 0.1 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 2.5 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.1 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.1 | 0.1 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 0.1 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 1.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.1 | 0.4 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 0.4 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.1 | 0.1 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.1 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.1 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.4 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.1 | 0.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 1.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.6 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.2 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 1.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.4 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.1 | 0.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.1 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.7 | GO:0045123 | cellular extravasation(GO:0045123) |
0.1 | 0.5 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
0.1 | 0.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.0 | 0.9 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.0 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 1.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.0 | 0.2 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.0 | 0.2 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.0 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.0 | 0.2 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.9 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.0 | 0.3 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 4.6 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.3 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.2 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.2 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.0 | 0.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0051767 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.0 | 0.1 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
0.0 | 0.2 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.0 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.8 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.0 | 1.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.3 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.8 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 27.9 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.3 | GO:0009593 | detection of chemical stimulus(GO:0009593) |
0.0 | 0.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.4 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.0 | 0.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0052205 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) |
0.0 | 0.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.3 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.0 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.0 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.0 | GO:1902713 | regulation of interferon-gamma secretion(GO:1902713) |
0.0 | 0.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.0 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.3 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 38.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
5.3 | 47.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.5 | 28.1 | GO:0005861 | troponin complex(GO:0005861) |
3.4 | 10.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
3.1 | 9.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
3.0 | 14.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.9 | 14.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.7 | 16.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.6 | 13.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.5 | 7.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.5 | 7.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
2.1 | 6.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.0 | 6.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.9 | 26.4 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
1.8 | 5.5 | GO:0048179 | activin receptor complex(GO:0048179) |
1.8 | 18.1 | GO:0031430 | M band(GO:0031430) |
1.8 | 5.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.8 | 17.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.8 | 5.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.7 | 5.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.5 | 10.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 15.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.5 | 112.9 | GO:0030018 | Z disc(GO:0030018) |
1.5 | 17.8 | GO:0005916 | fascia adherens(GO:0005916) |
1.5 | 4.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.5 | 20.4 | GO:0031674 | I band(GO:0031674) |
1.5 | 27.6 | GO:0030017 | sarcomere(GO:0030017) |
1.3 | 14.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.3 | 2.5 | GO:0032127 | dense core granule membrane(GO:0032127) |
1.3 | 3.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.2 | 7.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.2 | 3.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.2 | 4.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.1 | 7.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 6.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.0 | 4.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 4.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 8.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.0 | 20.4 | GO:0030016 | myofibril(GO:0030016) |
1.0 | 3.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
1.0 | 6.7 | GO:0042581 | specific granule(GO:0042581) |
1.0 | 3.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.9 | 9.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.9 | 4.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.9 | 5.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 7.2 | GO:0043292 | contractile fiber(GO:0043292) |
0.9 | 2.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.9 | 4.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 7.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.9 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.9 | 3.5 | GO:0044308 | axonal spine(GO:0044308) |
0.9 | 4.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.9 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 0.8 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.8 | 4.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.8 | 3.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.8 | 3.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 19.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 2.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.7 | 2.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 2.2 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 5.1 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.7 | 9.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.7 | 4.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.7 | 3.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.7 | 5.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.7 | 12.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.7 | 2.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.7 | 2.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.7 | 1.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.7 | 2.6 | GO:0097433 | dense body(GO:0097433) |
0.7 | 7.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.7 | 0.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.6 | 13.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.6 | 7.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 16.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 5.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 1.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 3.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.6 | 43.1 | GO:0042383 | sarcolemma(GO:0042383) |
0.6 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 3.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.6 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.6 | 1.8 | GO:0071546 | pi-body(GO:0071546) |
0.6 | 6.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 2.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.5 | 1.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 1.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.5 | 3.2 | GO:1990462 | omegasome(GO:1990462) |
0.5 | 2.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 28.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 5.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 6.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.5 | 3.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.5 | 2.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 1.5 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.5 | 0.5 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.5 | 3.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.5 | 10.8 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 2.8 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 40.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 5.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 1.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 1.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 6.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 1.3 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 2.8 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.4 | 2.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.4 | 2.4 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 1.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 4.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.4 | 5.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 21.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 1.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 1.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 1.0 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 2.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.3 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.3 | 1.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.0 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 0.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 1.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 5.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 0.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 0.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 1.0 | GO:0044299 | C-fiber(GO:0044299) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.3 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 0.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 5.0 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 2.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 2.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.3 | 1.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 12.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 1.5 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 4.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.5 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 6.5 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 6.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 8.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 6.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 1.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 2.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 2.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.3 | 2.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 2.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 0.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 10.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 1.2 | GO:0005818 | aster(GO:0005818) |
0.2 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.5 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 2.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 1.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 30.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 1.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 1.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 7.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 1.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 9.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 2.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 11.0 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.4 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 12.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 3.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.4 | GO:0038201 | TORC1 complex(GO:0031931) TOR complex(GO:0038201) |
0.2 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 0.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 6.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 6.0 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 2.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 3.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 3.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 9.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 2.6 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 9.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.2 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 2.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.2 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 31.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 5.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.2 | 6.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 4.6 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 2.8 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 1.8 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 1.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 7.6 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 6.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 5.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 9.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 12.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 2.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 2.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 3.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.8 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 7.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 10.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 14.9 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 1.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 1.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 5.8 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 4.2 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 2.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 0.5 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 2.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 11.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.1 | GO:1990777 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 1.9 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.0 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.0 | 0.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 19.5 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.0 | GO:1904949 | ATPase complex(GO:1904949) |
0.0 | 1.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.3 | 37.1 | GO:0031433 | telethonin binding(GO:0031433) |
4.9 | 14.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
4.8 | 9.6 | GO:0030172 | troponin C binding(GO:0030172) |
4.1 | 20.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.8 | 19.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.5 | 14.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
3.3 | 9.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
3.2 | 9.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
3.2 | 12.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.2 | 15.9 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.0 | 9.1 | GO:0031013 | troponin I binding(GO:0031013) |
2.7 | 5.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.7 | 8.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
2.6 | 7.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.4 | 7.3 | GO:0051373 | FATZ binding(GO:0051373) |
2.4 | 7.3 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.4 | 4.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.4 | 45.1 | GO:0030506 | ankyrin binding(GO:0030506) |
2.4 | 21.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.3 | 9.2 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.2 | 15.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.2 | 4.4 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.2 | 15.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
2.2 | 6.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
2.0 | 6.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
2.0 | 11.8 | GO:0004064 | arylesterase activity(GO:0004064) |
1.8 | 7.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.8 | 10.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.8 | 12.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.8 | 7.1 | GO:0043515 | kinetochore binding(GO:0043515) |
1.8 | 5.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.8 | 5.3 | GO:0035939 | microsatellite binding(GO:0035939) |
1.7 | 5.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.7 | 5.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.7 | 5.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.6 | 6.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.6 | 4.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.6 | 14.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.6 | 30.5 | GO:0030552 | cAMP binding(GO:0030552) |
1.6 | 16.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.6 | 3.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.6 | 11.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.6 | 1.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.6 | 6.2 | GO:0042731 | PH domain binding(GO:0042731) |
1.5 | 6.2 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.5 | 30.4 | GO:0003785 | actin monomer binding(GO:0003785) |
1.4 | 14.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.4 | 9.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.4 | 4.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.4 | 6.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.4 | 8.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.3 | 2.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.3 | 4.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 4.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.3 | 1.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.3 | 4.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.3 | 5.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
1.3 | 6.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.3 | 26.0 | GO:0042805 | actinin binding(GO:0042805) |
1.3 | 3.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.3 | 14.2 | GO:0017166 | vinculin binding(GO:0017166) |
1.3 | 3.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.3 | 11.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
1.3 | 10.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.3 | 3.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.3 | 1.3 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.2 | 3.7 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.2 | 5.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.2 | 9.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.2 | 2.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.2 | 1.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
1.2 | 7.3 | GO:0031432 | titin binding(GO:0031432) |
1.2 | 3.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.2 | 3.6 | GO:0071253 | connexin binding(GO:0071253) |
1.2 | 7.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.2 | 4.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.2 | 8.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
1.2 | 11.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.2 | 3.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.1 | 11.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.1 | 5.6 | GO:0043426 | MRF binding(GO:0043426) |
1.1 | 3.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.1 | 5.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.1 | 4.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.1 | 3.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
1.1 | 3.3 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
1.1 | 1.1 | GO:0043398 | HLH domain binding(GO:0043398) |
1.1 | 3.2 | GO:0051425 | PTB domain binding(GO:0051425) |
1.1 | 3.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 11.6 | GO:0031005 | filamin binding(GO:0031005) |
1.1 | 3.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.0 | 3.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.0 | 3.1 | GO:0055100 | adiponectin binding(GO:0055100) |
1.0 | 6.2 | GO:0043559 | insulin binding(GO:0043559) |
1.0 | 4.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.0 | 7.2 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 17.4 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.0 | 1.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.0 | 2.0 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.0 | 7.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.0 | 12.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.0 | 6.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.0 | 3.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.0 | 2.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 2.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.0 | 1.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.9 | 2.8 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.9 | 5.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 2.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.9 | 2.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.9 | 3.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.9 | 4.5 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.9 | 2.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.9 | 7.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.9 | 3.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.9 | 3.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.9 | 3.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.9 | 1.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 10.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.9 | 2.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 16.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.8 | 3.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 4.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.8 | 5.0 | GO:0015288 | porin activity(GO:0015288) |
0.8 | 15.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.8 | 8.4 | GO:0016208 | AMP binding(GO:0016208) |
0.8 | 6.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.8 | 3.3 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 2.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.8 | 3.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.8 | 2.5 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 4.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 27.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.8 | 6.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.8 | 16.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 3.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.8 | 4.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.8 | 5.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.8 | 3.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.8 | 3.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.8 | 5.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.8 | 3.0 | GO:0030984 | kininogen binding(GO:0030984) |
0.8 | 2.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.8 | 3.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.8 | 7.5 | GO:0001846 | opsonin binding(GO:0001846) |
0.7 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.7 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.7 | 4.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 2.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.7 | 0.7 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.7 | 3.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.7 | 3.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 0.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.7 | 3.5 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.7 | 2.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.7 | 4.8 | GO:0008688 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.7 | 9.0 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 2.0 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 21.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.7 | 11.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.7 | 2.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 2.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 2.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.7 | 2.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.7 | 19.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 1.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.6 | 3.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 2.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.6 | 3.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 2.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.6 | 3.7 | GO:0005536 | glucose binding(GO:0005536) |
0.6 | 2.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.6 | 1.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.6 | 3.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.6 | 3.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 4.3 | GO:0052812 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.6 | 4.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 2.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.6 | 3.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.6 | 1.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.6 | 1.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.6 | 12.6 | GO:0005537 | mannose binding(GO:0005537) |
0.6 | 3.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 2.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.6 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 7.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.6 | 2.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 6.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.6 | 0.6 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.6 | 2.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 1.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 4.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 1.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 2.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.6 | 3.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.6 | 1.7 | GO:0019961 | interferon binding(GO:0019961) |
0.6 | 3.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 2.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.5 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 1.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 1.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 2.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 4.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 4.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.5 | 2.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.5 | 1.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.5 | 1.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 2.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.5 | 2.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.5 | 1.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 1.5 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 1.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 1.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 2.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.5 | 1.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 1.5 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.5 | 14.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.5 | 1.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 2.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 3.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 1.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 7.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 2.8 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 1.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 2.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.5 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 3.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 1.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.5 | 1.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 2.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 4.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 2.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 0.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 4.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 2.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 4.5 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.4 | 6.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.4 | 1.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 1.8 | GO:0043829 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 3.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 4.3 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 3.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 1.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 0.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 5.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.4 | 1.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 3.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 3.7 | GO:0034582 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 39.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 8.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 4.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 0.8 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.4 | 1.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.4 | 2.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.4 | 4.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 3.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 0.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 1.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.4 | 1.6 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 3.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 4.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 3.4 | GO:0001848 | complement binding(GO:0001848) |
0.4 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 8.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 6.0 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 3.8 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.4 | 2.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.4 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 0.7 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.4 | 2.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.4 | 17.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 8.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.4 | 0.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.4 | 6.2 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 2.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 2.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 1.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 3.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.4 | 1.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 12.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 2.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 0.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 10.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 2.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 1.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.3 | 2.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.3 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 6.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 7.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.3 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 5.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.0 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.0 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 3.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 4.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.3 | 1.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 1.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 2.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 1.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.3 | 4.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.3 | 1.3 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.3 | 1.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 2.8 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.3 | 0.6 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 1.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.9 | GO:0018498 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.3 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 1.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.3 | 2.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.6 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.3 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 0.6 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 8.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 1.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 2.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 19.9 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.3 | 3.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 13.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 0.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 3.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 0.9 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.3 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 3.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 16.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.3 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.3 | 3.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.3 | 0.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 1.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.2 | 2.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 9.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.7 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 1.7 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 4.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 1.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 4.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 2.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 26.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 2.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 1.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 2.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 3.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 2.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 6.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 15.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 2.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.2 | 2.5 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.2 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 7.0 | GO:0060090 | binding, bridging(GO:0060090) |
0.2 | 0.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.6 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 4.9 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 2.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 5.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 1.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.8 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 2.1 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.2 | 1.5 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 3.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 3.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 1.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 2.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 13.5 | GO:0005496 | steroid binding(GO:0005496) |
0.2 | 5.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 2.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 0.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.2 | 1.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 1.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 3.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 34.9 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 0.7 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 4.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.1 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.2 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 1.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 1.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 3.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.2 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 4.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.4 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 3.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 4.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 1.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 2.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 3.5 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 2.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 4.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 1.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 3.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 3.4 | GO:0016684 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 0.5 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 2.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 35.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 1.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 6.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.9 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 2.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.2 | GO:0032557 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 1.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.1 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.1 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.1 | GO:0035671 | enone reductase activity(GO:0035671) |
0.1 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 3.4 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.1 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 4.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 2.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 1.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 3.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 2.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.0 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 1.6 | GO:0020037 | heme binding(GO:0020037) |
0.0 | 11.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 4.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.0 | 0.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.0 | 0.2 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.5 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.5 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 30.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.0 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.0 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 1.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.0 | 0.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.0 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 18.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.2 | 17.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.0 | 33.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.9 | 1.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 9.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 11.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 21.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.7 | 6.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.7 | 0.7 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.7 | 11.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.7 | 24.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.7 | 17.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.7 | 27.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.7 | 27.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 25.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 6.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 9.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 6.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 12.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 5.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 3.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.6 | 16.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.6 | 9.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.6 | 1.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 9.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 11.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.5 | 1.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 8.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 2.7 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 7.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 4.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.5 | 5.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 10.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 8.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 12.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.5 | 13.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.5 | 7.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 25.2 | PID P73PATHWAY | p73 transcription factor network |
0.5 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 7.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 7.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 5.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 10.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 6.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 17.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.4 | 2.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 2.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 3.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 12.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 1.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 3.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 1.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.4 | 1.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 1.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 0.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 9.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.3 | 5.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 5.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 2.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.3 | 2.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 4.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 3.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.3 | 1.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 1.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 1.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 2.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 4.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 4.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 8.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 4.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 2.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 5.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 3.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 2.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 4.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.3 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 88.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.9 | 26.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.5 | 31.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.5 | 33.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.3 | 13.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 22.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.3 | 21.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.2 | 2.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.2 | 4.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.2 | 15.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.1 | 14.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.1 | 13.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.1 | 19.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.0 | 12.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 4.9 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.0 | 12.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.9 | 14.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.9 | 7.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.9 | 4.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.9 | 17.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 12.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.9 | 1.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.9 | 1.7 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.8 | 6.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.8 | 3.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.8 | 3.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 12.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 21.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.7 | 11.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.7 | 5.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 6.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 7.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.7 | 8.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 7.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 20.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.7 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.7 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.7 | 7.8 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 1.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 3.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 5.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.6 | 6.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.6 | 5.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.6 | 6.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 2.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.6 | 19.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.6 | 7.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 5.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.6 | 1.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 3.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 49.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 8.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.5 | 3.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 13.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.5 | 1.6 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 7.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 1.6 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.5 | 1.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 8.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 3.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 4.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 2.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 4.0 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 19.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.5 | 9.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.5 | 10.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 2.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 7.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.5 | 8.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 6.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 1.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 13.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 8.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 4.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 6.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 4.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 7.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 6.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.4 | 4.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 14.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 4.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.4 | 9.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 0.7 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.4 | 2.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.4 | 3.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 2.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 5.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 3.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 4.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 2.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 10.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 13.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.3 | 21.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 7.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 8.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 5.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.3 | 2.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 4.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 3.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 0.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.3 | 2.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 1.6 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 0.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 1.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 26.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 1.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 6.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 3.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 2.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 3.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 12.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 5.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.2 | 7.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 2.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 9.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 0.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 1.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 1.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 5.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 2.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 2.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 6.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 4.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 1.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 1.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 1.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 5.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 4.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 0.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 4.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 9.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 1.7 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 0.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.2 | 3.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.2 | 2.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 0.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.9 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.1 | 2.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 5.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 0.1 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.7 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 3.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 5.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 2.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 11.7 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.1 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.7 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.0 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.0 | 0.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |